<qa>  What is the name of the study that is underway at the Reims University Hospital?Several molecular studies showed chromosomal alterations in patients with endometrial cancer, with gains in 1q, 19p, 19q, 8q, 10q and 10p and loss of 4q, 16q and 18q. Several genes of interest have been dentified P53, PTEN, PIK3CA, ß-catenin, K-ras .... It is thus conceivable that like that enable genomic tools used in breast cancer today Oncotype DX, MammaPrint, correlation between the tumor profile and life project in the case of cancer the endometrium could be done. A study is already underway at the Reims University Hospital with funding from the League against cancer and AOL in 2010 CHU Reims. It should identify the specific alterations of nosologic continuum of pathology and characterize areas of interest on the genome. To date, 39 patients with endometrial cancer and 15 patients with endometrial hyperplasia patients cases were included in the study. For this study, 10 patients exhibiting neither cancer nor endometrial hyperplasia were also included. Samples of these 10 patients witnesses were pooled to serve as a reference for analyzing patients cases. 